NO20006128L - Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmåte ved deres fremstillingog farmasöytiske sammensetning inneholdende dem - Google Patents

Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmåte ved deres fremstillingog farmasöytiske sammensetning inneholdende dem

Info

Publication number: NO20006128L
Authority: NO; Norway
Prior art keywords: alkyl; dihydro; nrr; benzoxazine; halo
Prior art date: 1999-12-06

Application number

NO20006128A

Other languages

English (en)

Other versions

NO317991B1 (no

NO20006128D0 (no

Inventor

Marie-Claude Viaud

Gerald Guillaumet

Philippe Daubos

Caroline Bennejean

Philippe Delagrange

Pierre Renard

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-06

Filing date

2000-12-01

Publication date

2001-06-07

2000-12-01 Application filed by Adir filed Critical Adir

2000-12-01 Publication of NO20006128D0 publication Critical patent/NO20006128D0/no

2001-06-07 Publication of NO20006128L publication Critical patent/NO20006128L/no

2005-01-17 Publication of NO317991B1 publication Critical patent/NO317991B1/no

Links

UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical class C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 title 1
CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 7
125000001475 halogen functional group Chemical group 0.000 abstract 3
PVTXJGJDOHYFOX-UHFFFAOYSA-N 2h-1,4-benzoxazine Chemical compound C1=CC=C2N=CCOC2=C1 PVTXJGJDOHYFOX-UHFFFAOYSA-N 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000002947 alkylene group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
FBOSKQVOIHEWAX-UHFFFAOYSA-N benzothiazine Chemical class C1=CC=C2N=CCSC2=C1 FBOSKQVOIHEWAX-UHFFFAOYSA-N 0.000 abstract 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
125000006684 polyhaloalkyl group Polymers 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000003282 alkyl amino group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003368 amide group Chemical group 0.000 abstract 1
235000010290 biphenyl Nutrition 0.000 abstract 1
239000004305 biphenyl Substances 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
125000002950 monocyclic group Chemical group 0.000 abstract 1
125000002757 morpholinyl group Chemical group 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000004193 piperazinyl group Chemical group 0.000 abstract 1
125000003386 piperidinyl group Chemical group 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

NO20006128A 1999-12-06 2000-12-01 Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmate ved deres fremstilling og farmasoytiske sammensetning inneholdende dem NO317991B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9915309A FR2801885B1 (fr)	1999-12-06	1999-12-06	Nouveaux derives (dihydro)benzoxaziniques et (dihydro) benzothiaziniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number	Publication Date
NO20006128D0 NO20006128D0 (no)	2000-12-01
NO20006128L true NO20006128L (no)	2001-06-07
NO317991B1 NO317991B1 (no)	2005-01-17

Family

ID=9552901

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006128A NO317991B1 (no)	1999-12-06	2000-12-01	Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmate ved deres fremstilling og farmasoytiske sammensetning inneholdende dem

Country Status (22)

Country	Link
US (1)	US6620809B2 (no)
EP (1)	EP1106608B1 (no)
JP (1)	JP3572012B2 (no)
KR (1)	KR100491601B1 (no)
CN (1)	CN1147482C (no)
AT (1)	ATE233744T1 (no)
AU (1)	AU774186B2 (no)
BR (1)	BR0005736A (no)
CA (1)	CA2328553A1 (no)
DE (1)	DE60001534T2 (no)
DK (1)	DK1106608T3 (no)
EA (1)	EA004762B1 (no)
ES (1)	ES2193926T3 (no)
FR (1)	FR2801885B1 (no)
HU (1)	HUP0004837A2 (no)
MX (1)	MX223546B (no)
NO (1)	NO317991B1 (no)
NZ (1)	NZ508631A (no)
PL (1)	PL344300A1 (no)
SI (1)	SI1106608T1 (no)
TR (1)	TR200300359T4 (no)
ZA (1)	ZA200007214B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060040931A1 (en) *	2002-12-06	2006-02-23	Toray Industries, Inc.	Benzomorpholine derivatives
FR2853649B1 (fr) *	2003-04-09	2006-07-14	Servier Lab	Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20090042874A1 (en) *	2007-05-30	2009-02-12	Wyeth	Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1173942A (en) *	1967-06-06	1969-12-10	Bellon Labor Sa Roger	New 2,3-Dihydro-1,4-Benzoxazines
CA2035147A1 (en) *	1990-02-08	1991-08-09	Kousuke Yasuda	Thiazine (or oxazine) derivatives and preparation thereof
IL137656A0 (en) *	1998-03-31	2001-10-31	Warner Lambert Co	Benzoxazinones/benzothiazinones as serine protease inhibitors

1999
- 1999-12-06 FR FR9915309A patent/FR2801885B1/fr not_active Expired - Fee Related
2000
- 2000-12-01 NO NO20006128A patent/NO317991B1/no unknown
- 2000-12-04 MX MXPA00011967 patent/MX223546B/es active IP Right Grant
- 2000-12-05 JP JP2000369913A patent/JP3572012B2/ja not_active Expired - Fee Related
- 2000-12-05 ES ES00403399T patent/ES2193926T3/es not_active Expired - Lifetime
- 2000-12-05 DE DE60001534T patent/DE60001534T2/de not_active Expired - Fee Related
- 2000-12-05 TR TR2003/00359T patent/TR200300359T4/xx unknown
- 2000-12-05 DK DK00403399T patent/DK1106608T3/da active
- 2000-12-05 NZ NZ508631A patent/NZ508631A/en unknown
- 2000-12-05 PL PL00344300A patent/PL344300A1/xx not_active Application Discontinuation
- 2000-12-05 AT AT00403399T patent/ATE233744T1/de not_active IP Right Cessation
- 2000-12-05 SI SI200030062T patent/SI1106608T1/xx unknown
- 2000-12-05 US US09/730,119 patent/US6620809B2/en not_active Expired - Fee Related
- 2000-12-05 EP EP00403399A patent/EP1106608B1/fr not_active Expired - Lifetime
- 2000-12-05 EA EA200001157A patent/EA004762B1/ru not_active IP Right Cessation
- 2000-12-06 AU AU72073/00A patent/AU774186B2/en not_active Ceased
- 2000-12-06 BR BR0005736-3A patent/BR0005736A/pt not_active IP Right Cessation
- 2000-12-06 CN CNB001372513A patent/CN1147482C/zh not_active Expired - Fee Related
- 2000-12-06 ZA ZA200007214A patent/ZA200007214B/xx unknown
- 2000-12-06 HU HU0004837A patent/HUP0004837A2/hu unknown
- 2000-12-06 CA CA002328553A patent/CA2328553A1/fr not_active Abandoned
- 2000-12-06 KR KR10-2000-0073761A patent/KR100491601B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO317991B1 (no)	2005-01-17
NZ508631A (en)	2002-03-01
NO20006128D0 (no)	2000-12-01
MXPA00011967A (es)	2002-05-23
TR200300359T4 (tr)	2004-02-23
CA2328553A1 (fr)	2001-06-06
EP1106608A1 (fr)	2001-06-13
EA200001157A3 (ru)	2001-08-27
ATE233744T1 (de)	2003-03-15
FR2801885B1 (fr)	2002-01-11
KR100491601B1 (ko)	2005-05-27
CN1147482C (zh)	2004-04-28
CN1308069A (zh)	2001-08-15
US20010003747A1 (en)	2001-06-14
HK1038741A1 (en)	2002-03-28
HUP0004837A2 (hu)	2002-04-29
HU0004837D0 (no)	2001-02-28
BR0005736A (pt)	2001-07-17
AU7207300A (en)	2001-06-07
MX223546B (es)	2004-10-19
ZA200007214B (en)	2001-06-06
SI1106608T1 (en)	2003-06-30
DE60001534T2 (de)	2004-01-08
JP3572012B2 (ja)	2004-09-29
DE60001534D1 (de)	2003-04-10
JP2001187787A (ja)	2001-07-10
AU774186B2 (en)	2004-06-17
FR2801885A1 (fr)	2001-06-08
EP1106608B1 (fr)	2003-03-05
EA004762B1 (ru)	2004-08-26
PL344300A1 (en)	2001-06-18
ES2193926T3 (es)	2003-11-16
DK1106608T3 (da)	2003-06-02
EA200001157A2 (ru)	2001-06-25
US6620809B2 (en)	2003-09-16
KR20010062170A (ko)	2001-07-07

Publication	Publication Date	Title
DE69428476D1 (de)	2001-11-08	Heterocyclische Verbindungen als Bradykinin Antagonisten
NO995175D0 (no)	1999-10-22	Nye dihydro- og tetrahydrokinolinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NZ231062A (en)	1991-09-25	((1,2 benzisoxazol-3-yl)piperidinyl alkyl)-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimdin-4-one derivatives and antipsychotic compositions
EP1389617A4 (en)	2006-03-29	Heterocyclic compound and antitumor agent containing it as an active ingredient
IL144461A0 (en)	2002-05-23	Quinoline and quinazoline derivatives and pharmaceutical compositions containing them
NO982784L (no)	1998-08-17	Kinazolin-derivater
EA199800348A1 (ru)	1998-10-29	Замещенные тетрациклические производные тетрагидрофурана
AU3113793A (en)	1993-03-11	Intermediates for preparing antipicornaviral pyridazinamines
IL113778A (en)	1999-09-22	Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
DE60214401D1 (de)	2006-10-12	Hetero-bicyclische crf antagonisten
AU6785201A (en)	2002-01-14	Novel pyrazinone derivatives
NO20006128D0 (no)	2000-12-01	Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetning inneholdende dem
CA2254755A1 (en)	1997-11-27	Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
SI1103554T1 (en)	2003-08-31	Derivatives of dihydrofuro-(3,4-b)-quinolein-1-ones, process of preparation and phamaceutical compositions containing them
NO20005390L (no)	2001-04-30	Nye forbindelser av 9-(3,5-dimetyloksyfenyl)-5,8,8a,9- tetrahydrofuro[3',4':6,7]nafto[2,3-d]-[1,3]dioksol-6(5aH)-on,fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem
NO20002940L (no)	2000-12-18	Nye forbindelser av 7-okso-2,3,7,14-tetrahydro-1H-benzo- [b]pyrano[3,2-h]akridinkarboksylat, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
EA200200379A2 (ru)	2002-10-31	Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
AU3017397A (en)	1998-02-05	New bisimide compounds, process for preparing them and pharmaceutical compositions containing them
NO996285L (no)	2000-06-19	Nye spiroimidazolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
AU653019B2 (en)	1994-09-15	New urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same